AlphaFold predicted structure
U2AF2 · P26368

Mean pLDDT
73.2/ 100
Confident
475 residues
Confidence breakdown
- Very high(≥ 90)31%
- Confident(70–90)33%
- Low(50–70)11%
- Very low(< 50)25%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
U2 small nuclear RNA auxiliary factor 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinteddevelopmental delay, dysmorphic facies, and brain anomalies
neurodevelopmental disorder
hereditary disease
Intellectual disability
acute myeloid leukemia
dengue disease
neurodegenerative disease
leukodystrophy
stroke disorder
alcohol drinking
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Splicing factor U2AF 65 kDa subunit
Plays a role in pre-mRNA splicing and 3'-end processing (PubMed:17024186). By recruiting PRPF19 and the PRP19C/Prp19 complex/NTC/Nineteen complex to the RNA polymerase II C-terminal domain (CTD), and thereby pre-mRNA, may couple transcription to splicing (PubMed:21536736). Induces cardiac troponin-T (TNNT2) pre-mRNA exon inclusion in muscle. Regulates the TNNT2 exon 5 inclusion through competition with MBNL1. Binds preferentially to a single-stranded structure within the polypyrimidine tract of TNNT2 intron 4 during spliceosome assembly. Required for the export of mRNA out of the nucleus, even if the mRNA is encoded by an intron-less gene. Represses the splicing of MAPT/Tau exon 10. Positively regulates pre-mRNA 3'-end processing by recruiting the CFIm complex to cleavage and polyadenylation signals (PubMed:17024186)
Curated MONDO disease pages that list U2AF2 among their top associated genes.
U2AF2 · P26368

Mean pLDDT
73.2/ 100
Confident
475 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0